NASDAQ · Medical - Healthcare Information Services

HTFL (HTFL) Stock

$28.82 +5.99% NASDAQ: HTFL Healthcare

Valuation

MetricValue
Price$28.82
Market Cap$2.49B
P/E Ratio-101.97
P/B Ratio8.35
P/S Ratio12.76
EPS (TTM)$-3.17
52-Week High$41.22
52-Week Low$20.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-1.11%
ROA-16.75%
ROCE-21.33%
Gross Margin76.80%
Operating Margin-36.13%
Net Margin-58.42%
Debt/Equity0.09
Current Ratio5.20

Annual Financials (USD)

Metric202320242025
Revenue$87.0M$126.0M$176.0M
Operating Profit$-73.0M$-61.0M$-64.0M
Net Profit$-96.0M$-96.0M$-117.0M
EPS$-1.94$-1.49$-1.37
Op Margin-83.6%-48.7%-36.4%

Balance Sheet (USD)

Metric202320242025
Total Assets$185.0M$119.0M$359.0M
Total Liabilities$963.0M$978.0M$59.0M
Cash$123.0M$51.0M$45.0M
Borrowings$161.0M$160.0M$22.0M

Latest News

What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors? Motley Fool · Jul 15, 2026 New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management GlobeNewswire · Jul 9, 2026 Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? Motley Fool · Jul 8, 2026 Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? Motley Fool · Jul 4, 2026 Heartflow Insider Sold Shares Worth $1,361,500, According to a Recent SEC Filing MT Newswires · Jun 29, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-76.0M$-69.0M$-54.0M
Investing Cash Flow$-12.0M$-9.0M$-244.0M
Financing Cash Flow$0$2.0M$-1.0M
Net Cash Flow$86.0M$-71.0M$-7.0M
Free Cash Flow$-83.0M$-73.0M$-59.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-37.82
FCF Yield-2.34%
Quick Ratio5.20
Interest Coverage-4.27
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATEC $9.65 +3.54% -8.57 $1.48B 0.00%
IRON $73.86 -1.01% -9.08 $2.82B 0.00%
LEGNLegend Biotech Corporation $23.58 +0.17% -17.34 $4.36B 0.00%
LIVN $81.43 -0.80% 36.61 $4.47B 0.00%
PRGO $12.84 +2.39% -1.06 $1.78B 10.86%

About HTFL

HTFL stock trades at $28.82 with a market capitalization of $2.49B. The stock is valued at a price-to-earnings (P/E) ratio of -101.97, price-to-book of 8.35, price-to-sales of 12.76. Over the past 52 weeks the stock has ranged between $20.13 and $41.22, and currently trades 30.1% below its 52-week high.

On profitability, HTFL generates a return on equity (ROE) of -1.11%, return on capital employed of -21.33%, an operating margin of -36.13%, a net profit margin of -58.42%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides